Delivery Order SPE2DB20D7059-SPE2DB25FQHF9

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of ETONOGESTREL-EE VAGINAL RINGS. The $1,585.23 firm fixed price contract has a completion date of July 3, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE vaginal rings. The contract has a firm fixed price of $3,709.62 and a performance period ending on April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,448.40 firm fixed-price contract is for the delivery of Etonogestrel-EE Vaginal Rings, a prescription contraceptive product. The contract has a completion date of September 27, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Etonogestrel-EE Vaginal Rings. The contract has a ceiling value of $3,699.36 and a period of performance through April 16, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the supply of Etonogestrel-EE Vaginal Rings. The order has a firm fixed-price contract type and a ceiling value of $1,623.36. The ultimate completion date is August 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of Etonogestrel-EE Vaginal Rings, a pharmaceutical product. The contract has a ceiling value of $1,798.24 and an ultimate completion date of March 29, 2023. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,644.69, is for the delivery of Etonogestrel-EE Vaginal Rings, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. The contract was not designated with a set-aside requirement, indicating open...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $77,146.62 firm fixed-price contract is for the supply of etonogestrel-EE vaginal rings, a type of contraceptive. The contract has an ultimate completion date of August 19, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Etonogestrel-EE Vaginal Rings, a type of contraceptive device, with a ceiling value of $1,592.44 and a completion date of September 23, 2024. The contract is a firm-fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,176.63 and a completion date of December 13, 2024. It is a firm-fixed-price contract for the procurement of ETONOGESTREL-EE VAGINAL RINGS, a type of medical product. No set-aside designation was used for this award. AmerisourceBergen holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQHF9
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,345.05 firm fixed price contract is for the delivery of ETONOGESTREL-EE VAGINAL RINGS, with a completion date of May 29, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/27/25, 9:56 AM